2-es típusú cukorbetegség: vizsgálatok itt: Kína
193 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisTaking peoplePhase III Study of UBT251 Injection in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Diet and Exercise Alone(UNIGUIDE-1)
- Where
- Changsha
- Életkor
- 18 év to 75 év
- People
- 360
- Run by
- The United Bio-Technology (Hengqin) Co., Ltd.
See details and how to joinNCT07659574 - 4. fázisTaking peopleIntervention for High-normal Blood Pressure in Adults With Type 2 Diabetes
- Where
- Guangzhou
- Életkor
- 45 év to 79 év
- People
- 11 414
- Run by
- XueQing Yu
See details and how to joinNCT03264352 - 3. fázisTaking peoplePhase III Study of UBT251 Injection in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Metformin ± Sulfonylurea/SGLT2 Inhibitor Therapy (UNIGUIDE-2)
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 956
- Run by
- The United Bio-Technology (Hengqin) Co., Ltd.
See details and how to joinNCT07653477 - 4. fázisTaking peopleFingolimod for Type 2 Diabetes Mellitus
- Where
- Shenyang
- Életkor
- 18 év to 70 év
- People
- 40
- Run by
- General Hospital of Shenyang Military Region
See details and how to joinNCT05307731 - 2. fázisTaking peoplePhase 2 Clinical Study of MWN109 Tablets in Participants With Type 2 Diabetes Mellitus
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 240
- Run by
- Shanghai Minwei Biotechnology Co., Ltd
See details and how to joinNCT07801820 - No phaseTaking peopleEffect of Continuous Glucose Monitoring System on Glycemic Control in Non-insulin-Treated Elderly People With Type 2 Diabetes
- Where
- Shenzhen
- Életkor
- 60 év and over
- People
- 148
- Run by
- Shanghai 6th People's Hospital
See details and how to joinNCT07007676 - 1. fázisNot yet taking people in KínaA Clinical Study to Evaluate the Safety and Efficacy of RGB-5088 in Patients With Type 2 Diabetes Mellitus
- Where
- Beijing
- Életkor
- 18 év to 65 év
- People
- 10
- Run by
- Hangzhou Reprogenix Bioscience, Inc
See details and how to joinNCT07794254 - 1. fázisTaking peoplePhase 1 Clinical Study of MWN105 Injection in Participants With Overweight or Obesity
- Where
- Kunming
- Életkor
- 18 év to 50 év
- People
- 36
- Run by
- Shanghai Minwei Biotechnology Co., Ltd
See details and how to joinNCT07803809 - 3. fázisTaking peopleMazdutide in Type 2 Diabetes With Early-Stage Cognitive Impairment (LIGHT-COG Study)
- Where
- Changsha, Changzhou, Dalian, Nanjing, Shanghai
- Életkor
- 50 év to 75 év
- People
- 420
- Run by
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT07083154 - 3. fázisNot yet taking people in KínaA Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
- Where
- Binzhou, Changsha, Chengdu, Hangzhou, Jinan, Liaocheng, Liuzhou, Luoyang, Nanjing, Nanyang, Suining Shi, Yibin, Yichang, Zhengzhou
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662135 · EU 2025-523940-12-00 - 2. fázisNot yet taking people in KínaA Study of SYH2069 Injection in Participants With T2DM Not Controlled With Diet/Exercise Alone or Metformin
- Where
- Nanjing
- Életkor
- 18 év to 75 év
- People
- 240
- Run by
- CSPC Ouyi Pharmaceutical Co., Ltd.
See details and how to joinNCT07796477 - 3. fázisNot yet taking people in KínaAMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Where
- Beijing, Cangzhou, Changchun, Changde, Changzhou, Chengdu, Chongqing, Hefei, Huzhou, Jilin City, Jinan, Kaifeng, Langfang, Luoyang, Nanjing, Nanyang, Panjin, Shanghai, Shenzhen, Shijiazhuang, Shiyan, Suzhou, Xining, Zhengzhou, Zhenjiang
- Életkor
- 45 év and over
- People
- 1778 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07797335 - 3. fázisNot yet taking people in KínaA Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- Where
- Baotou, Binzhou, Cangzhou, Changsha, Chengdu, Ganzhou, Haikou, Hangzhou, Huangshi, Huzhou, Jinan, Jinzhou, Lanzhou, Lianyungang, Liaocheng, Liuzhou, Loudi, Luoyang, Nanchang, Nanjing, Nanyang, Ningbo, Panjin, Qingdao, Sanmenxia, Shanghai, Suining Shi, Tonghua, Xi'an, Xiangtan, Xuancheng, Yibin, Yichang, Yuncheng, Zhengzhou, Zhenjiang
- Életkor
- 18 év and over
- People
- 800 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662044 · EU 2025-523936-37-00 - 2. fázisNot yet taking people in KínaA Study to Evaluate the Efficacy and Safety of DA-302168S Tablets in Subjects With Type 2 Diabetes
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 272
- Run by
- Chendu DIAO Pharmaceutical Group CO., LTD.
See details and how to joinNCT07755150 - 1. fázisTaking peopleA Clinical Trial Evaluating TQF3250 Capsules in Patients With Type 2 Diabetes Mellitus and Overweight/Obesity
- Where
- Changsha, Fuzhou, Guangzhou, Hangzhou, Jinan, Langfang, Luoyang, Luzhou, Nanjing, Shanghai, Wuhan, Yichang
- Életkor
- 18 év to 70 év
- People
- 72
- Run by
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
See details and how to joinNCT07747857 - No phaseNot yet taking people in KínaClinical Evaluation of Salivary 1,5-Anhydroglucitol in Diabetes
- Where
- Shanghai
- Életkor
- 18 év to 80 év
- People
- 180
- Run by
- Shanghai 6th People's Hospital
See details and how to joinNCT07781683 - No phaseNot yet taking people in KínaMetformin-Dapagliflozin Effects on IGF-1 in Male T2DM With MASLD
- Where
- Putian
- Életkor
- 30 év to 60 év
- People
- 84
- Run by
- The 95th Hospital of Putian,Putian, Fujian, China
See details and how to joinNCT07778719 - No phaseNot yet taking people in KínaCEEEC-II: A 12-Week Physical and Cognitive Enrichment Extension Study in Older Stroke Survivors With Multimorbidity
- Where
- Kunshan
- Életkor
- 60 év and over
- People
- 365
- Run by
- Duke Kunshan University
See details and how to joinNCT07778771 - No phaseNot yet taking people in KínaRowing and Cycling Reduce Inflammation in Early-Stage Type 2 Diabetes
- Where
- Putian
- Életkor
- 18 év to 60 év
- People
- 120
- Run by
- The 95th Hospital of Putian,Putian, Fujian, China
See details and how to joinNCT07769840 - No phaseNot yet taking people in KínaMazdutide for Remission of Type 2 Diabetes: Multicentre, Double Blind, Randomised, Placebo Controlled Trial
- Where
- Guangzhou
- Életkor
- 18 év to 70 év
- People
- 249
- Run by
- Yanbing Li
See details and how to joinNCT07767552 - No phaseNot yet taking people in KínaEfficacy and Safety of Hebenrun in Patients With Type 2 Diabetes
- Where
- Nanchang
- Életkor
- 18 év to 65 év
- People
- 110
- Run by
- Jiangxi University of Traditional Chinese Medicine
See details and how to joinNCT07768280 - 4. fázisNot yet taking people in KínaInsulin Icodec Initiation Strategies and Day-4 Supplemental Dosing in Type 2 Diabetes
- Where
- Xi'an
- Életkor
- 18 év and over
- People
- 462
- Run by
- Xi'an International Medical Center Hospital
See details and how to joinNCT07747402 - 3. fázisNot yet taking people in KínaA Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
- Where
- Changsha, Hefei, Huai'an, Langfang, Liangyugang, Luoyang, Nanjing, Nanyang, Pinggu, Pingxiang, Shijiazhuang, Tianjin, Yueyang
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07664553 · EU 2025-523935-20-00 - No phaseNot yet taking people in KínaBlood-based sEV Proteins for Early Detection of 2 Diabetes
- Where
- Luzhou
- Életkor
- 40 év to 59 év
- People
- 120 worldwide
- Run by
- Hong Kong Baptist University
See details and how to joinNCT07728591 - No phaseNot yet taking people in KínaPoint-of-care Capillary HbA1c Testing for Type 2 Diabetes Screening Among At-risk Individuals in Rural Dali, China
- Where
- Dali
- Életkor
- 18 év and over
- People
- 720
- Run by
- The University of Hong Kong
See details and how to joinNCT07718867